Baker Botts L.L.P.
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Baker Botts L.L.P. advises life sciences clients on the IP, litigation, and corporate transactional matters associated with bringing pharmaceutical products, medical devices, and research tools to market. The firm also supports clients on business development initiatives and corporate transactions within the sector, including identifying and evaluating potential investment targets, mergers, and acquisitions. Steve Lendaris, firmwide life sciences sector chair and based in New York, advises on a range of biotechnology-related IP matters, including evaluating third-party patents ahead of product launches and developing patent filing strategies for new therapeutic approaches.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The Baker Botts team has been very responsive to our needs. They have taken complex problems (e.g. IP) and worked through them to provide solid guidance and solutions.’
‘Their ability to quickly understand/comprehend complex problems and offer thoughtful solutions.'
Key clients
- Agni Bio, Inc.
- Alga Biosciences
Work highlights
Handles a wide variety of diligence and prosecution matters for Genentech, a leading biotechnology company and member of the Roche family of companies.